Traynor Capital Management, Inc. Exact Sciences Corp Transaction History

Traynor Capital Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$56.27 - $73.77 $341,952 - $448,300	6,077 Added 7.63%	85,765 $5.92 Million
Q4 2023 Jan 18, 2024	BUY	$59.06 - $75.72 $659,995 - $846,171	11,175 Added 16.31%	79,688 $5.9 Million
Q3 2023 Oct 16, 2023	BUY	$65.94 - $99.04 $2.54 Million - $3.81 Million	38,448 Added 127.88%	68,513 $4.67 Million
Q2 2023 Jul 28, 2023	BUY	$62.68 - $95.05 $284,379 - $431,241	4,537 Added 17.77%	30,065 $2.82 Million
Q1 2023 Apr 21, 2023	BUY	$47.19 - $70.77 $458,026 - $686,893	9,706 Added 61.34%	25,528 $1.73 Million
Q4 2022 Jan 27, 2023	BUY	$30.35 - $53.15 $480,197 - $840,939	15,822 New	15,822 $0
Q4 2018 Jan 24, 2019	SELL	$56.04 - $82.66 $222,759 - $328,573	-3,975 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$37.84 - $69.96 $150,414 - $278,091	3,975 New	3,975 $240,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Traynor Capital Management, Inc. with notifications on news.